Mayo Clinic [clinicaltrials_resource:cd3bb14d0168fffd6084bad83da37656]
Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [clinicaltrials:NCT00002693]Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003690]17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery [clinicaltrials:NCT00004075]Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004260]Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis [clinicaltrials:NCT00004482]Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00005068]Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma [clinicaltrials:NCT00006243]PS-341 in Treating Patients With Advanced Cancer [clinicaltrials:NCT00006362]Risk Factors for Venous Thromboembolism in the Community [clinicaltrials:NCT00011180]clinicaltrials:NCT00012298Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00021073]BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00022542]PS-341 in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00024011]PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00028587]2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00028821]Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis [clinicaltrials:NCT00030381]Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer [clinicaltrials:NCT00033462]Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer [clinicaltrials:NCT00039104]Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00045201]Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00047047]Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [clinicaltrials:NCT00047190]Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00047203]Aerobic Exercise Intervention for Knee Osteoarthritis [clinicaltrials:NCT00049816]Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00055757]Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00064324]Nutritional Restriction and Activity Thermogenesis [clinicaltrials:NCT00065338]clinicaltrials:NCT00068822Regional Fatty Acid Metabolism in Humans [clinicaltrials:NCT00068887]FFA Metabolism in Different Types of Human Obesity [clinicaltrials:NCT00068900]Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression [clinicaltrials:NCT00069407]Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors [clinicaltrials:NCT00074321]Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [clinicaltrials:NCT00075439]Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) [clinicaltrials:NCT00077441]clinicaltrials:NCT00083122Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas [clinicaltrials:NCT00085371]Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00085553]CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor [clinicaltrials:NCT00087074]clinicaltrials:NCT00089076clinicaltrials:NCT00093496Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00094848]
location [clinicaltrials_vocabulary:location]
Mayo Clinic [clinicaltrials_resource:cd3bb14d0168fffd6084bad83da37656]
Bio2RDF identifier
cd3bb14d0168fffd6084bad83da37656
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cd3bb14d0168fffd6084bad83da37656
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:cd3bb14d0168fffd6084bad83da37656
title
Mayo Clinic
@en
type
label
Mayo Clinic [clinicaltrials_resource:cd3bb14d0168fffd6084bad83da37656]
@en